Hyperghrelinemia in the patients presenting with Prader-Willi syndrome

Bogova E.A.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" Minzdrava RF, Moskva

Volevodz N.N.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Il'in A.V.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Peterkova V.A.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Hyperghrelinemia in the patients presenting with Prader-Willi syndrome

Authors:

Bogova E.A., Volevodz N.N., Il'in A.V., Peterkova V.A.

More about the authors

Journal: Problems of Endocrinology. 2014;60(3): 30‑37

DOI: 10.14341/probl201460330-37

Downloaded: 4

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Bogova EA, Volevodz NN, Il'in AV, Peterkova VA. Hyperghrelinemia in the patients presenting with Prader-Willi syndrome. Problems of Endocrinology. 2014;60(3):30‑37. (In Russ.)
https://doi.org/10.14341/probl201460330-37

Close metadata

Recommended articles:

Electric activity of the brain at early and late clinical stages of experimental modeling of Parkinson’s disease, an impact of hemantane. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):129-134

The present study was designed to measure pre- and postprandial ghrelin secretion in the children presenting with Prader-Willi syndrome (PWS). The clinical, hormonal, and metabolic characteristics of 17 prepubertal children with the genetically verified diagnosis of PWS, 15 patients with exogenous-constitutional obesity, and 10 healthy children are presented. The children suffering PWS were found to exhibit pre- and postprandial hyperghrelinemia.

Keywords:

streptozotocin-induced diabetes

mitochondria

MPTP

glycorazmulin

oxidative phosphorylation

Authors:

Bogova E.A.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" Minzdrava RF, Moskva

Volevodz N.N.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Il'in A.V.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Peterkova V.A.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

List of references:

Haworth R.A., Hunter D.R. The Ca2+-induced membrane transition in mitochondria. Arch Biochem Biophys 1979; 195: 2: 460-467. doi: 10.1016/0003-9861(79)90372-2.
Szewczyk A. Mitochondria as a Pharmacological Target. Pharmacol Rev 2002; 54: 1: 101-127. doi: 10.1124/pr.54.1.101.
Zhilyuk V.I., Mamchur V.I., Pavlov S.V., Bukhtiyarova N.V. Vliyanie sredstv s nootropnymi i neyroprotektornymi svoystvami na protsessy energeticheskogo metabolizma i proyavleniya mitokhondrial'noy disfunktsii v neyronakh golovnogo mozga krys s alloksanovym diabetom. Probl Endocrinol 2010; 3: 69-74.
Szabadkai G., Duchen M.R. Mitochondria mediated cell death in diabetes. Apoptosis 2009; 14: 12: 1405-1423. doi: 10.1007/s10495-009-0363-5.
Victor V.M., Rocha M., Banuls C., Bellod L., Hernandez-Mijares A. Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes. Curr Pharm Des 2011; 17: 20: 1986-2001.
Skulachev V.P. Zakony bioenergetiki. Sorosovskiy obrazovatel'nyy zhurnal 1997; 1: 9-14.
Kroemer G., Dallaporta B., Resche-Rigon M. The Mitochondrial Death/Life Regulator in Apoptosis and Necrosis. Ann Rev Physiol 1998; 60: 1: 619-642. doi: 10.1146/annurev.physiol.60.1.619.
Maechler P., Li N., Casimir M., Vetterli L., Frigerio F., Brun T. Role of Mitochondria in &Bgr;-cell. Funct Dysfunct 2010; 654: 193-216. doi: 10.1007/978-90-481-3271-3-9.
Rakhmatullaeva M.M., Aminov S.N. Elementnyy sostav gipoglikemicheskogo sredstva "Glikorazmulin". Farmatsevt zhurn 2005; 3: 42.
Faizieva Z.T. Effect of glycorazmulin on blood biochemical characteristics in alloxan diabetes. Probl Endokrinol 2009; 55: 5: 26-27.
Aripova T.U., Aminov S.N., Batyrbekov A.A. et al. Vliyanie glikorazmulina i ego komponentov na immunnuyu sistemu v eksperimente. Zhurnal teoreticheskoy i klinicheskoy meditsiny 2007; 2: 6-8.
Schneider W.C., Hageboom G.H., Pallade G.E. Cytochemical studies of mammalian tissues; isolation of intact mitochondria from rat liver; some biochemical properties of mitochondria and submicroscopic particulate material. J Biol Chem 1948; 172: 2: 619-635.
Almatov K.T., Akhmerov R.N., Aulov D.M., Rakhimov M.M. Vydelenie mitokhondriy iz podzheludochnoy zhelezy. Uzbek bioly zhurn 1977; 3: 30-32.
He L. Heat Shock Suppresses the Permeability Transition in Rat Liver Mitochondria. J Biol Chem 2003; 278: 19: 16755-16760. doi: 10.1074/jbc.M300153200.
Mitochondria in pathology. Ed by. M.N. Kondrashova, Yu.G. Kaminskiy, E.I. Maevskiy. Pushchino 2001.
Peterson G.L. A simplification of the protein assay method of Lowry et al. Which is more generally applicable. Ann Biochem 1977; 83: 2: 346-356. doi: 10.1016/0003-2697(77)90043-4.
Eskina K.A., Vasil'ev K.Yu. Vliyanie yantarya-antitoksa i silimarina na okislitel'noe fosforilirovanie i perekisnoe okislenie lipidov v pecheni krys pri eksperimental'nom sakharnom diabete. Bull Sib Med 2006; 5: 2: 101-106.
Kaldybaeva A.O., Abdusamatov A.A. Vliyanie kornya solodki, tsvetkov bessmertnika i mumie na pokazateli perekisnogo okisleniya lipidov pri khronicheskom toksicheskom gepatite. Med zhurn Uzbek 2010; 3: 99-101.
Simonova N.V., Dorovskikh V.A., Shtarberg M.A. The influence of vegetal adaptogens on the intensity of lipid peroxidation processes of biomembranes during ultraviolet irradiation. Dal'nevost Med zhurn 2010; 2: 112-115.

Close metadata